: TGTX

TG Therapeutics (NASDAQ: TGTX)

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States. Take a look at the 1-year chart of TG (NASDAQ: TGTX) below with the added notations: During the past year, TGTX has created two key price levels to… Continue Reading »

TG Therapeutics Inc (NASDAQ: TGTX)

TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases primarily in the United States.